|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: LINC01006 |
Gene summary for LINC01006 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | LINC01006 | Gene ID | 100506380 |
| Gene name | long intergenic non-protein coding RNA 1006 | |
| Gene Alias | C7orf13 | |
| Cytomap | 7q36.3 | |
| Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 100506380 | LINC01006 | LZE7T | Human | Esophagus | ESCC | 1.62e-04 | 1.90e-01 | 0.0667 |
| 100506380 | LINC01006 | LZE20T | Human | Esophagus | ESCC | 1.20e-05 | 1.74e-01 | 0.0662 |
| 100506380 | LINC01006 | LZE22T | Human | Esophagus | ESCC | 1.57e-02 | 1.99e-01 | 0.068 |
| 100506380 | LINC01006 | LZE24T | Human | Esophagus | ESCC | 5.01e-24 | 5.54e-01 | 0.0596 |
| 100506380 | LINC01006 | LZE6T | Human | Esophagus | ESCC | 1.62e-02 | 1.33e-01 | 0.0845 |
| 100506380 | LINC01006 | P1T-E | Human | Esophagus | ESCC | 2.97e-02 | 1.42e-01 | 0.0875 |
| 100506380 | LINC01006 | P2T-E | Human | Esophagus | ESCC | 8.01e-26 | 3.80e-01 | 0.1177 |
| 100506380 | LINC01006 | P4T-E | Human | Esophagus | ESCC | 1.36e-04 | 1.06e-01 | 0.1323 |
| 100506380 | LINC01006 | P5T-E | Human | Esophagus | ESCC | 3.15e-13 | 2.88e-01 | 0.1327 |
| 100506380 | LINC01006 | P8T-E | Human | Esophagus | ESCC | 1.07e-13 | 2.19e-01 | 0.0889 |
| 100506380 | LINC01006 | P9T-E | Human | Esophagus | ESCC | 2.41e-06 | 1.46e-01 | 0.1131 |
| 100506380 | LINC01006 | P10T-E | Human | Esophagus | ESCC | 3.14e-37 | 6.41e-01 | 0.116 |
| 100506380 | LINC01006 | P11T-E | Human | Esophagus | ESCC | 6.08e-06 | 2.14e-01 | 0.1426 |
| 100506380 | LINC01006 | P12T-E | Human | Esophagus | ESCC | 1.39e-32 | 6.35e-01 | 0.1122 |
| 100506380 | LINC01006 | P15T-E | Human | Esophagus | ESCC | 7.88e-24 | 4.85e-01 | 0.1149 |
| 100506380 | LINC01006 | P16T-E | Human | Esophagus | ESCC | 1.67e-40 | 7.28e-01 | 0.1153 |
| 100506380 | LINC01006 | P17T-E | Human | Esophagus | ESCC | 2.60e-06 | 2.31e-01 | 0.1278 |
| 100506380 | LINC01006 | P19T-E | Human | Esophagus | ESCC | 6.53e-04 | 2.91e-01 | 0.1662 |
| 100506380 | LINC01006 | P20T-E | Human | Esophagus | ESCC | 3.70e-51 | 9.01e-01 | 0.1124 |
| 100506380 | LINC01006 | P21T-E | Human | Esophagus | ESCC | 1.29e-30 | 5.57e-01 | 0.1617 |
| Page: 1 2 3 4 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |